Cargando…
Advances in Doxorubicin-based nano-drug delivery system in triple negative breast cancer
Triple positive breast cancer (TPBC) is one of the most aggressive breast cancer. Due to the unique cell phenotype, aggressiveness, metastatic potential and lack of receptors or targets, chemotherapy is the choice of treatment for TNBC. Doxorubicin (DOX), one of the representative agents of anthracy...
Autores principales: | Zeng, Weiwei, Luo, Yuning, Gan, Dali, Zhang, Yaofeng, Deng, Huan, Liu, Guohui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693343/ https://www.ncbi.nlm.nih.gov/pubmed/38047286 http://dx.doi.org/10.3389/fbioe.2023.1271420 |
Ejemplares similares
-
Advances in dendritic cell targeting nano-delivery systems for induction of immune tolerance
por: Lin, Guojiao, et al.
Publicado: (2023) -
Recent advances in nano-drug delivery systems for synergistic antitumor immunotherapy
por: Zhao, Bonan, et al.
Publicado: (2022) -
Advances in the research of nano delivery systems in ischemic stroke
por: Li, Yi-Xuan, et al.
Publicado: (2022) -
Corrigendum: Advances in the research of nano delivery systems in ischemic stroke
por: Li, Yi-Xuan, et al.
Publicado: (2023) -
Application of the Nano-Drug Delivery System in Treatment of Cardiovascular Diseases
por: Deng, Yudi, et al.
Publicado: (2020)